Johann Sellner
Overview
Explore the profile of Johann Sellner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
165
Citations
2009
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hochmeister S, Rakusa M, Moro E, Bereczki D, Cavallieri F, Fanciulli A, et al.
Neurol Sci
. 2025 Feb;
PMID: 39903350
Background: An online 3-item survey was sent to the European Academy of Neurology (EAN) community and inquired about the persistence of SARS-CoV-2 vaccination skepticism and the underlying thoughts and factors...
2.
Halsby K, Dobler G, Easton A, Karelis G, Krbkova L, Kyncl J, et al.
Ticks Tick Borne Dis
. 2024 Dec;
16(1):102431.
PMID: 39708718
Categorization systems for tick-borne encephalitis virus (TBEV) infection lack consistency in classifying disease severity. To evaluate the need for a standard, consensus-based categorisation system for TBEV infection across subtypes, we...
3.
Halsby K, Gildea L, Madhava H, Angulo F, Pilz A, Erber W, et al.
Ticks Tick Borne Dis
. 2024 Nov;
15(6):102407.
PMID: 39500220
Tick-borne encephalitis (TBE) is caused by a viral infection and can lead to acute and persistent damage to the central and peripheral nervous systems. Recently, the incidence of TBE in...
4.
Filipovic S, Ozturk S, Bereczki D, Bodini B, Cavallieri F, Fanciulli A, et al.
Eur J Neurol
. 2024 Aug;
31(10):e16408.
PMID: 39088330
Background And Purpose: In October 2020, the European Academy of Neurology (EAN) consensus statement for management of patients with neurological diseases during the coronavirus disease 2019 (COVID-19) pandemic was published....
5.
Moser T, Foettinger F, Hitzl W, Novotna B, Berger T, Bsteh G, et al.
Ann Clin Transl Neurol
. 2024 May;
11(6):1442-1455.
PMID: 38715245
Background/objective: Observational real-world study to analyze the clinical effects of alemtuzumab (ALEM) and subsequent disease-modifying therapy (DMT) usage in multiple sclerosis (MS). Methods: Data retrieved from the Austrian MS treatment...
6.
Waiss C, Strobele B, Graichen U, Klee S, Gartlehner J, Sonntagbauer E, et al.
J Cent Nerv Syst Dis
. 2024 May;
16:11795735241247026.
PMID: 38706882
Background: 'Definite Neuroborreliosis (NB)' is diagnosed with the presence of NB-specific symptoms, cerebrospinal fluid (CSF) pleocytosis and an elevated antibody index. However, some diagnostic uncertainties exist. The B-cell chemokine CXCL13...
7.
Cavallieri F, Sellner J, Akhvlediani T, Bassetti C, Bereczki D, Fanciulli A, et al.
Eur J Neurol
. 2024 Apr;
32(1):e16321.
PMID: 38676302
Background: The COVID-19 pandemic has made its mark on world history forever causing millions of deaths, and straining health systems, economies, and societies worldwide. The European Academy of Neurology (EAN)...
8.
Fox R, Wiendl H, Wolf C, De Stefano N, Sellner J, Gryb V, et al.
Neurol Neuroimmunol Neuroinflamm
. 2024 Apr;
11(3):e200208.
PMID: 38662979
Background And Objectives: Vidofludimus calcium suppressed MRI disease activity compared with placebo in patients with relapsing-remitting multiple sclerosis (RRMS) in the first cohort of the phase 2 EMPhASIS study. Because...
9.
Mitsikostas D, Caronna E, de Tommaso M, Deligianni C, Ekizoglu E, Bolay H, et al.
Eur J Neurol
. 2024 Apr;
31(7):e16308.
PMID: 38628031
No abstract available.
10.
Mitsikostas D, Caronna E, de Tommaso M, Deligianni C, Ekizoglu E, Bolay H, et al.
Eur J Neurol
. 2024 Feb;
31(6):e16251.
PMID: 38415282
Background And Purpose: The aim was to provide insights to the characteristics of headache in the context of COVID-19 on behalf of the Headache Scientific Panel and the Neuro-COVID-19 Task...